Hypervascular hepatocellular carcinoma in the cirrhotic liver: Diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI

Magnetic Resonance Imaging

Volumn 29, Issue 9, 2011, Pages 1235-1243

  Chung, Jin ^a   Yu, Jeong Sik ^a   Kim, Dae Jung ^a   Chung, Jae Joon ^a   Kim, Joo Hee ^a   Kim, Ki Whang ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Diffusion; Hepatocellular carcinoma; Liver; Magnetic resonance; Superparamagnetic iron oxide (SPIO)

Indexed keywords

FERUCARBOTRAN; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; HYPERVASCULAR LIVER CELL CARCINOMA; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FERRIC COMPOUNDS; FIBROSIS; GADOLINIUM DTPA; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; RADIOLOGY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

SPIO;

EID: 80054777913     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2011.07.025     Document Type: Article

References (34)

1. Nakashima Y., Nakashima O., Tanaka M., Okuda K., Nakashima M., Kojiro M. Portal vein invasion and intrahepatic micrometastases in small hepatocellular carcinoma by gross type. Hepatol Res 2003, 26:142-147.
2. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001, 35:421-430.
3. Yu J.S., Kim K.W., Jeong M.G., Lee J.T., Yoo H.S. Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 2000, 217:750-756.
4. Motosugi U., Ichikawa T., Sou H. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology 2010, 256:151-158.
5. Forner A., Vilana R., Ayuso C., et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008, 47:97-104.
6. Sangiovanni A., Manini M.A., Iavarone M., et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010, 59:638-644.
7. Bruix J., Sherman M., Practice Guidelines Committee, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
8. Bruix J., Sherman M., American Association for the Study of Liver Diseases Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022.
9. Imai Y., Murakami T., Yoshida S., et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histologic grading. Hepatology 2000, 32:205-212.
10. Elizondo G., Weissleder T., Stark D.D., et al. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 1990, 174:797-801.
11. Xu P.J., Yan F.H., Wang J.H., Lin J., Ji Y. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging 2009, 29:341-349.
12. Vandecaveye V., Keyzer F.D., Verslype C., et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 2009, 19:2456-2466.
13. Earls J.P., Rofsky N.M., DeCorato D.R., Krinsky G.A., Weinreb J.C. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997, 202:268-273.
14. Yu J.S., Lee J.H., Chung J.J., Kim J.H., Kim K.W. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Acta Radiol 2008, 49:735-743.
15. Mori K., Yoshioka H., Itai Y., et al. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. AJR Am J Roentgenol 2000, 175:1659-1664.
16. Yu J.S., Chung J.J., Kim J.H., Kim K.W. Small hypervascular hepatocellular carcinomas: value of "washout" on gadolinium-enhanced dynamic MR imaging compared to superparamagnetic iron oxide-enhanced imaging. Eur Radiol 2009, 19:2614-2622.
17. Demir O.I., Obuz F., Saǧol O., Dicle D. Contribution of diffusion-weighted MRI to the differential diagnosis of hepatic masses. Diagn Interv Radiol 2007, 13:81-86.
18. Naganawa S., Kawai H., Fukatsu H., et al. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. J Magn Reson Med 2005, 4:175-186.
19. Namimoto T., Yamashita Y., Sumi S., Tang Y., Takahashi M. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997, 204:739-744.
20. Kim T., Murakami T., Takahashi S., Hori M., Tsuda K., Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999, 173:393-398.
21. Nasu K., Kuroki Y., Nawano S., et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006, 239:122-130.
22. Zech C.J., Herrmann K.A., Dietrich O., Horger W., Reiser M.F., Schoenberg S.O. Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging: comparison with a standard T2-weighted sequence for detection of focal liver lesions. Invest Radiol 2008, 43:261-266.
23. Coenegrachts K., Orlent H., Neek L.T., et al. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI. J Magn Reson Imaging 2008, 27:117-124.
24. Van den Bos I.C., Hussain S.M., Dwarkasing R.S., et al. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. J Magn Reson Imaging 2007, 26:1548-1555.
25. Morana G., Grazioli L., Testoni M., Caccia P., Procacci C. Contrast agents for hepatic magnetic resonance imaging. Top Magn Reson Imaging 2002, 13:117-150.
26. Ward J., Feng C., Guthrie J.A., et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 2000, 214:159-166.
27. Lim J.H., Choi D., Cho S.K., et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 2001, 220:669-676.
28. Nasu K., Kuroki Y., Tsukamoto T., Nakajima H., Mori K., Minami M. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. Am J Roentgenol 2009, 193:438-444.
29. Edmondson H.A., Steiner P.E. Primary carcinoma of liver: study of 100 cases among 48,900 necropsies. Cancer 1954, 7:462-503.
30. Naganawa S., Sato C., Nakamura T., et al. Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. J Magn Reson Imaging 2005, 21:836-840.
31. Bruegel M., Holzapfel K., Gaa J., et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008, 18:477-485.
32. Moteki T., Ishizaka H., Horikoshi H., Matsumoto M. Differentiation between hemangiomas and hepatocellular carcinomas with the apparent diffusion coefficient calculated from turbo FLASH MR images. J Magn Reson Imaging 1995, 5:191-197.
33. Quan X.Y., Sun X.J., Yu Z.J., Tang M. Evaluation of diffusion weighted imaging of magnetic resonance imaging in small focal hepatic lesions: a quantitative study in 56 cases. Hepatobiliary Pancreat Dis Int 2005, 4:406-409.
34. Kim S.Y., Lee S.S., Byun J.H., et al. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology 2010, 255:815-823.